Day One Biopharmaceuticals, Inc. (DAWN) EPS by Year
DAWN
Day One Biopharmaceuticals, Inc. lost $1.04 per diluted share in fiscal year 2025. This represents a decrease of 2.0% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Day One Biopharmaceuticals, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$1.04
YoY-2.0%
Source SEC Filings (10-K/10-Q)Latest period FY2025, ended Dec 31, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
DAWN EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Day One Biopharmaceuticals, Inc.'s diluted earnings per share in fiscal year 2025?
Day One Biopharmaceuticals, Inc. lost $1.04 per diluted share in fiscal year 2025.
How fast is Day One Biopharmaceuticals, Inc.'s diluted earnings per share growing?
Day One Biopharmaceuticals, Inc. (DAWN) diluted earnings per share fell by 2.0% year over year, from -$1.02 to -$1.04 in fiscal year 2025.
What was Day One Biopharmaceuticals, Inc.'s diluted earnings per share in the most recent quarter?
Day One Biopharmaceuticals, Inc. (DAWN) reported -$0.21 in diluted earnings per share in Q4 2025. This represents an increase of 69.6% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Day One Biopharmaceuticals, Inc. (DAWN) reported on that line in every period on record.
